Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heart Research Centers International (HRCI) was a clinical research organization (CRO) that specialized in the management and execution of cardiovascular clinical trials. Based in Charlotte, North Carolina, the company operated as a subsidiary of MedCath Corporation, a healthcare provider known for its national network of specialized heart hospitals. HRCI leveraged this hospital network to provide pharmaceutical and medical device companies with access to specialized investigators and patient populations for cardiac research. The company provided a range of services including trial design, site monitoring, and regulatory support specifically tailored to the cardiovascular field. While active during the late 1990s and 2000s, HRCI ceased operations following the strategic liquidation and sale of MedCath's assets in the early 2010s. Its legacy is tied to the integrated model of combining specialized cardiac care facilities with dedicated clinical research capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heart Research Centers International.